| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 223.30B | 216.83B | 210.95B | 204.36B | 192.19B |
| Gross Profit | 133.04B | 158.25B | 155.17B | 154.75B | 150.16B |
| EBITDA | 116.37B | 85.66B | 89.78B | 93.44B | 90.85B |
| Net Income | 30.69B | 32.31B | 26.61B | 10.48B | 26.37B |
Balance Sheet | |||||
| Total Assets | 634.51B | 623.27B | 609.52B | 624.16B | 626.33B |
| Cash, Cash Equivalents and Short-Term Investments | 12.23B | 11.00B | 17.09B | 25.80B | 33.42B |
| Total Debt | 359.04B | 335.62B | 302.34B | 292.01B | 274.24B |
| Total Liabilities | 506.49B | 506.54B | 499.13B | 510.20B | 498.86B |
| Stockholders Equity | 126.83B | 115.42B | 105.22B | 108.73B | 123.22B |
Cash Flow | |||||
| Free Cash Flow | 23.85B | 13.45B | 7.33B | -19.35B | -12.01B |
| Operating Cash Flow | 85.35B | 81.73B | 85.77B | 76.20B | 91.97B |
| Investing Cash Flow | -60.27B | -65.70B | -55.12B | -33.01B | -103.64B |
| Financing Cash Flow | -23.20B | -22.33B | -39.42B | -42.30B | -4.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $17.79B | 16.17 | 15.56% | 6.14% | -5.21% | -7.45% | |
72 Outperform | $5.22B | 10.60 | 7.24% | 5.57% | 19.02% | 9.26% | |
70 Outperform | $24.55B | 17.32 | 9.03% | 5.03% | -3.16% | 4.70% | |
64 Neutral | $4.61B | 9.02 | 24.66% | 7.78% | 0.59% | 8.86% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | $33.74B | 7.35 | -8.37% | 3.77% | 19.67% | -278.51% |